IDR 2360.0
(-2.07%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4264.27 Billion IDR | 5.32% |
2022 | 4048.93 Billion IDR | -6.98% |
2021 | 4352.86 Billion IDR | 27.3% |
2020 | 3419.34 Billion IDR | 6.69% |
2019 | 3205.02 Billion IDR | 18.13% |
2018 | 2713.08 Billion IDR | 8.71% |
2017 | 2495.71 Billion IDR | 2.47% |
2016 | 2435.46 Billion IDR | 13.77% |
2015 | 2140.7 Billion IDR | 10.03% |
2014 | 1945.5 Billion IDR | 11.68% |
2013 | 1742.09 Billion IDR | 18.08% |
2012 | 1475.39 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 1166.48 Billion IDR | -3.55% |
2024 Q1 | 1243.05 Billion IDR | 12.26% |
2024 Q2 | 1209.44 Billion IDR | -2.7% |
2023 Q2 | 1021.21 Billion IDR | -0.61% |
2023 Q4 | 1107.3 Billion IDR | -0.08% |
2023 Q3 | 1108.24 Billion IDR | 8.52% |
2023 FY | 4264.27 Billion IDR | 5.32% |
2023 Q1 | 1027.51 Billion IDR | 5.28% |
2022 FY | 4048.93 Billion IDR | -6.98% |
2022 Q3 | 1000.3 Billion IDR | 2.08% |
2022 Q4 | 975.96 Billion IDR | -2.43% |
2022 Q2 | 979.95 Billion IDR | -10.32% |
2022 Q1 | 1092.7 Billion IDR | 15.47% |
2021 Q4 | 946.3 Billion IDR | -6.93% |
2021 FY | 4352.86 Billion IDR | 27.3% |
2021 Q3 | 1016.73 Billion IDR | -14.27% |
2021 Q2 | 1186.03 Billion IDR | -1.48% |
2021 Q1 | 1203.79 Billion IDR | 9.09% |
2020 FY | 3419.34 Billion IDR | 6.69% |
2020 Q4 | 1103.47 Billion IDR | 26.18% |
2020 Q1 | 874.71 Billion IDR | 6.4% |
2020 Q2 | 566.63 Billion IDR | -35.22% |
2020 Q3 | 874.51 Billion IDR | 54.33% |
2019 Q4 | 822.11 Billion IDR | 2.96% |
2019 FY | 3205.02 Billion IDR | 18.13% |
2019 Q3 | 798.46 Billion IDR | 2.39% |
2019 Q2 | 779.79 Billion IDR | -3.09% |
2019 Q1 | 804.63 Billion IDR | 18.27% |
2018 Q2 | 671.09 Billion IDR | -3.42% |
2018 Q1 | 694.83 Billion IDR | 7.11% |
2018 FY | 2713.08 Billion IDR | 8.71% |
2018 Q4 | 680.36 Billion IDR | 2.03% |
2018 Q3 | 666.79 Billion IDR | -0.64% |
2017 Q1 | 631.47 Billion IDR | 3.93% |
2017 Q2 | 605.49 Billion IDR | -4.12% |
2017 FY | 2495.71 Billion IDR | 2.47% |
2017 Q4 | 648.69 Billion IDR | 6.33% |
2017 Q3 | 610.05 Billion IDR | 0.75% |
2016 Q1 | 625.15 Billion IDR | 16.04% |
2016 FY | 2435.46 Billion IDR | 13.77% |
2016 Q4 | 607.6 Billion IDR | 7.27% |
2016 Q3 | 566.43 Billion IDR | -10.98% |
2016 Q2 | 636.28 Billion IDR | 1.78% |
2015 Q3 | 500.11 Billion IDR | -10.79% |
2015 Q4 | 538.72 Billion IDR | 7.72% |
2015 FY | 2140.7 Billion IDR | 10.03% |
2015 Q1 | 541.28 Billion IDR | 13.19% |
2015 Q2 | 560.58 Billion IDR | 3.56% |
2014 Q2 | 507.29 Billion IDR | 2.94% |
2014 Q4 | 478.2 Billion IDR | 2.36% |
2014 FY | 1945.5 Billion IDR | 11.68% |
2014 Q3 | 467.18 Billion IDR | -7.91% |
2014 Q1 | 492.82 Billion IDR | 0.0% |
2013 FY | 1742.09 Billion IDR | 18.08% |
2012 FY | 1475.39 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Bundamedik Tbk | 1488.19 Billion IDR | -186.54% |
PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -1657.156% |
PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 26.276% |
PT Murni Sadar Tbk | 921.91 Billion IDR | -362.546% |
PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | -131.851% |
PT Royal Prima Tbk | 265.33 Billion IDR | -1507.119% |
PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -1042.014% |
PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | -177.688% |
PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 61.894% |
PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | -70.355% |